Latest 10-Q quarterly reports

Equitable Holdings, Inc. announced its first quarter 2026 financial results, showcasing a significant increase in net income attributable to Holdings, driven by favorable expense management and reinsurance transactions, alongside progress on its proposed merger with Corebridge.

MGT Capital Investments, Inc. filed its Q1 2026 10-Q, detailing a significant operational transition with no active revenue-generating operations and a focus on liquidity and strategic alternatives.

Helmerich & Payne reports a net loss for the quarter ended March 31, 2026, impacted by asset impairments and integration costs, despite a growing contract backlog.

Amneal Pharmaceuticals reports a significant increase in net income and gross profit for Q1 2026, driven by robust performance in its Specialty segment and improved manufacturing efficiencies.

Varex Imaging Corporation's Q2 filing shows a 1.5% revenue increase to $216.0 million, but a net loss of $8.1 million compared to a profit in the prior year.

GPGI, Inc. filed its Q1 2026 10-Q, detailing significant changes in its financial reporting structure and the impact of the Husky Transaction, resulting in a net loss for the quarter.

Arlo Technologies Inc. reported a significant increase in total revenue and a return to profitability in its first quarter of 2026, driven by strong subscription growth and improved product sales.

Crinetics Pharmaceuticals reports strong Q1 2026 results driven by PALSONIFY commercialization, with significant revenue growth and increased R&D investment.

Lexicon Pharmaceuticals reports a significant revenue increase driven by milestone payments, alongside a reduced net loss for the first quarter of 2026.

Eastman Kodak Company announced its first quarter 2026 financial results, reporting a 7% increase in total revenues to $265 million, driven by strong performance in its Print segment.

Synaptics Incorporated announced its third quarter fiscal year 2026 results, reporting a 10.4% increase in net revenue to $294.2 million and a narrowed net loss compared to the prior year period.

Codexis, Inc. announced its first quarter 2026 financial results, reporting a significant increase in total revenues driven by strong growth in research and development revenue.

Tectonic Therapeutics, Inc. reported a net loss of $25.2 million for the first quarter of 2026, with research and development expenses increasing significantly.

RXO, Inc. reported a slight revenue decrease for the first quarter of 2026, with net loss widening due to increased costs and debt extinguishment charges, despite a rise in truck brokerage revenue.

Amrize Ltd. reported a 4.7% increase in Q1 2026 revenue to $2.18 billion, but a wider net loss of $118 million, impacted by increased SG&A and softer demand in the Building Envelope segment.

SiriusPoint Ltd. announced a significant increase in net income and improved underwriting results for the first quarter of 2026, driven by strong performance in its Insurance & Services segment and reduced catastrophe losses.

Alta Equipment Group Inc. reported a 3.0% decrease in total revenues for the first quarter of 2026, driven by lower equipment sales and rental income, alongside margin pressures.

Affiliated Managers Group (AMG) announced a significant increase in net income and assets under management for the first quarter of 2026, driven by strong performance across its diverse investment strategies.

ZipRecruiter reported a 2% year-over-year revenue decrease for Q1 2026, but improved profitability with a positive Adjusted EBITDA.

First Advantage Corporation announced its first quarter 2026 financial results, showcasing an 8.6% increase in revenue and a significant swing to net income.

TechTarget, Inc. reported its first quarter 2026 financial results, highlighting a revenue increase but also significant goodwill impairment charges and ongoing efforts to remediate internal control weaknesses.

Myomo Inc. reported a 3% increase in Q1 2026 revenue to $10.11 million, but net loss widened to $3.01 million, impacted by increased operating expenses and derivative liability revaluation.

Hess Midstream LP reports increased revenues and Adjusted EBITDA for Q1 2026, driven by higher tariff rates and third-party services, despite slight decreases in throughput volumes.

Universal Health Realty Income Trust reports steady revenues and a slight increase in net income for Q1 2026, with FFO growth driven by higher depreciation.

The RealReal reports Q1 2026 results with a 18% increase in consignment revenue driven by higher GMV, though take rate decreased due to sales mix.

Definium Therapeutics reported increased operating expenses and a wider net loss in Q1 2026, driven by significant investment in its DT120 and DT402 clinical programs, while advancing key trials.

Assembly Biosciences reports Q1 2026 financial results, highlighting progress in its viral disease pipeline and ongoing collaboration with Gilead Sciences.

CAMP4 Therapeutics reports increased collaboration revenue in Q1 2026, but a wider net loss driven by derivative liability revaluation.

SITE Centers Corp. reports a net income of $938,000 for Q1 2026, a decrease from $3,085,000 in Q1 2025, driven by property dispositions and impairment charges.

CarGurus reported a 15% increase in Q1 2026 revenue to $243.6 million, but net income from continuing operations decreased to $32.2 million from $42.1 million in the prior year, impacted by a significant impairment charge.